Membrane fluidity in malignancy. Adversative and recuperative.
D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D006528:Carcinoma, Hepatocellular / Q000503:physiopathology; D002471:Cell Transformation, Neoplastic / Q000648:ultrastructure; D002784:Cholesterol / Q000032:analysis; D002788:Cholesterol Esters / Q000494:pharmacology; D005227:Fatty Acids / Q000032:analysis; D006706:Homeostasis; D006801:Humans; D007167:Immunotherapy; D007938:Leukemia / Q000503:physiopathology; D008113:Liver Neoplasms / Q000503:physiopathology; D008223:Lymphoma / Q000503:physiopathology; D008560:Membrane Fluidity; D008563:Membrane Lipids / Q000032:analysis; D008958:Models, Molecular; D009369:Neoplasms / Q000503:physiopathology*; D010714:Phosphatidylethanolamines / Q000032:analysis; D011379:Prognosis; D013109:Sphingomyelins / Q000032:analysis; D014611:Vaccination; D014783:Viscosity
D000951:Antigens, Neoplasm; D002788:Cholesterol Esters; D005227:Fatty Acids; D008563:Membrane Lipids; D010714:Phosphatidylethanolamines; D013109:Sphingomyelins; D002784:Cholesterol; C013440:cholesteryl succinate